Human gene
F11 coagulation factor XI
2 disease groups in OMIA reach this gene, through the animal gene that Ensembl gives as its ortholog. The page shows the chain. It does not say whether an animal is a model of a human disease.
Animal diseases
By each group's best natural-model score, highest first. How the score works.
| OMIA group | Name | Species | Animal gene | Ortholog | The chain reached | Best score |
|---|---|---|---|---|---|---|
| 363 | Factor XI deficiency | dog | F11 | one to one | Drug |
69.4
|
| 363 | Factor XI deficiency | domestic cattle | F11 | one to one | Drug |
69.4
|
| 819 | Prekallikrein deficiency | dog | KLKB1 | one to one | Drug |
64.9
|
Target evidence
Each Open Targets association between this gene and a human disease that a disease group reached.
| Human disease | Mondo | Score | Evidence |
|---|---|---|---|
| congenital factor XI deficiency | MONDO:0012897 | 0.77 | 319 |
| inherited prekallikrein deficiency | MONDO:0012901 | 0.03 | 2 |
Drugs
Each ChEMBL drug that acts on this gene.
| Drug | How | Latest stage |
|---|---|---|
| Human C1-Esterase Inhibitor | inhibitor | Approved |
| Abelacimab | inhibitor | Phase 3 |
| Milvexian | inhibitor | Phase 3 |
| Osocimab | negative allosteric modulator | Phase 2 |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.